Blue Turtle Bio Overview
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Blue Turtle Bio General Information
Description
Developer of a bio-engineered probiotic therapeutics platform designed to treat rare genetic diseases through the gut. The company's probiotic therapeutics platform engineered gut microbe secretes an enzyme, glucocerebrosidase, enabling healthcare providers to treat Gaucher's disease.
Contact Information
Website
www.blueturtlebio.comCorporate Office
- 479 Jessie Street
- Lower Nob Hill
- San Francisco, CA 94103
- United States
Corporate Office
- 479 Jessie Street
- Lower Nob Hill
- San Francisco, CA 94103
- United States
Blue Turtle Bio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Out of Business | 15-Jul-2017 | Completed | Out of Business | |||
4. Early Stage VC | 23-Aug-2016 | Cancelled | Startup | |||
3. Accelerator/Incubator | 23-Feb-2015 | Completed | Startup | |||
2. Grant | $5K | Completed | Startup | |||
1. Accelerator/Incubator | 01-Jan-2012 | Completed | Startup |
Blue Turtle Bio FAQs
-
Where is Blue Turtle Bio headquartered?
Blue Turtle Bio is headquartered in San Francisco, CA.
-
What industry is Blue Turtle Bio in?
Blue Turtle Bio’s primary industry is Drug Discovery.
-
Is Blue Turtle Bio a private or public company?
Blue Turtle Bio is a Private company.
-
What is Blue Turtle Bio’s current revenue?
The current revenue for Blue Turtle Bio is
. -
How much funding has Blue Turtle Bio raised over time?
Blue Turtle Bio has raised $250K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »